Background
swapnil hiremath
The SGLT2i Crescendo with CREDENCE

This week, we will discuss the CREDENCE trial, simply the most important nephrology trial in a generation.

The SGLT2i Crescendo with CREDENCE
Background
swapnil hiremath
How can we ASCEND from the depths of ...

This week we look at the treatment of depression in hemodialysis patients. It is cognitive behavorial therapy versus sertraline.

How can we ASCEND from the depths of depression?

SMART

The Fluid Wars Return: Can we restore Balance to the field

The Fluid Wars Return: Can we restore Balance to the field

March 13/14 we will discuss the pair of trials in NEJM from Vanderbilt: comparing balanced solutions to normal saline in critically ill & not ill patients. Join us for the next #NephJC to parse through SMART & SALT-ED